Atlas Trials

The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis

Clinical trial NCT00171639 · COMPLETED

Trial details

NCT number
NCT00171639
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2004-06-01
Primary completion
2007-03-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.